Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Kintor Approved to Begin China Phase II Trial for Pulmonary Fibrosis Candidate

publication date: Oct 12, 2023

Suzhou Kintor Pharma announced conditional China approval for a Phase II trial of its small molecule Hedgehog/SMO inhibitor to treat idiopathic pulmonary fibrosis (IPF). Currently, there are no effective therapies to stop or cure the fibrosis process of IPF, though the Hedgehog signaling pathway become a target for addressing the disease. GT1708F is a highly active and specific inhibitor of SMO protein, which lowers activity of the Hedgehog pathway and expression of its downstream proteins, thereby treating IPF. Previously, GT1708F showed a good safety trial in a China Phase I trial for patients with hematologic malignancies. More details....

Stock Symbol: (HK: 9939)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital